Post-doctoral fellow and/or a pharmacist M/F

DETALLES DE LA OPORTUNIDAD

Recompensa total

0 $

Universidad Estatal

Institut Gustave Roussy

Área

Europa Oriental

País anfitrión

Francia

Fecha límite

20 jul. 2021

Nivel de estudio

Doctorado

Tipo de oportunidad

Postdoctorado

Especialidades

Medicamento , Biología

Oportunidad de financiación

No financiación

Países elegibles

Esta oportunidad está destinada a todos los países

Región elegible

Todas las regiones

Gustave Roussy, Europe's leading cancer research center, is recruiting.

The UMR-1015 of Gustave Roussy directed by Pr. Laurence ZITVOGEL is interested in the immunology of cancer and the mechanisms of action of immunotherapies.

The U1015 INSERM in close cooperation with the Department of Oncology Medicine (DMO) launched the epidemiological and clinical study ONCOVID during the health crisis to improve the management of advanced cancer patients in our institute infected or not by SARS-CoV-2. This clinical program consisted of the inclusion of 470 patients and the constitution of a biobank of approximately 8000 specimens allowing the investigation of the pathophysiological disorders associated with the infection and compromising the response of patients to their anticancer treatment. In May 2020, we launched our research program, consisting of high dimensional immunological analysis called "ONCOVID I" (Spectral flow cytometry, MSD ELISA) and functional analysis (in vitro antigen specific innate and acquired immunity tests) called ONCOVID II, of all included COVID-19+ or COVID-19-negative patients (controls). In addition, the IHU Méditerranée Infections sent us samples from 100 non-cancerous patients to be treated at the same time (PROTECT-CoV study). In this context, we have established collaboration with an industrial company in order to transform the current assay into a quasi-automated assay, without changing the sensitivity or the specificity of the test, for a potential large-scale use of the signature assay. In this context, we are looking for a post-doctoral fellow and/or a pharmacist M/F

In the context of the ONCOVID I and II program, as Project Manager, your missions will include the coordination of the implementation and smooth running of the study:

Expertise in organizational and managerial management is essential.

Knowledge in immunology and cell biology techniques is required. The use of R software is a plus.

Written and spoken English

Abilities :

- Adaptability

- Sense of analysis and synthesis

- Ability to interact and work in a team

- Rigor, method and dynamism

- Knowledge of tools related to immunology (flow cytometry, immunolabeling, ELISA, multiplex)

- Competence in the use of fundamental computer tools

- Participation in the organizational management of the team

Education:

Holder of a PhD in the field of immunology and/or a pharmacy thesis

Type of contract : 12 months fixed term contract, renewable, with prospects of longer term employment, remuneration to be adjusted according to experience.

As part of our proactive policy in favor of the integration of disabled persons, all applications received are considered on an equal basis.

Please send a cover letter specifying your salary expectations and CV under the reference:

Karthiga KANAGASABAI

Chargée de recrutement

Direction de la Recherche

B2M, RDC, pièce 81

01 42 11 57 30